CVR: 39270684
Previous names: Kariya Pharmaceuticals IVS
Kariya Pharmaceuticals ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Kariya Pharmaceuticals IVS. The management consists of Christian Hölscher. The company's owners include JUMIKA Holdings ApS, Thomsen Pharma ApS and MAC Clinical Research Finance Ltd.. In 2025, the company reported a gross profit of DKK -32,093,186 and a net result of DKK -26,490,250 compared with DKK -2,599,412 the year before. Equity amounted to DKK -25,206,578.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileVirksomhedens formål er forskning og udvikling af lægemidler samt dermed beslægtet virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -32.1 mio. | -26.5 mio. | 38.9 mio. | -25.2 mio. | 0 | |
| 2024 | -3.6 mio. | -2.6 mio. | 2.3 mio. | 1.3 mio. | 1 | |
| 2023 | -10.2 mio. | -8 mio. | 2.1 mio. | -6.4 mio. | 1 | |
| 2022 | -13.8 mio. | -14 mio. | 2.2 mio. | -26.7 mio. | 1 | |
| 2021 | -2.7 mio. | -3.3 mio. | 1.1 mio. | -12.7 mio. | 1 | |
| 2020 | -1.5 mio. | -2.2 mio. | 1.7 mio. | -9.5 mio. | 2 | |
| 2019 | -6.3 mio. | -7.3 mio. | 3.2 mio. | -7.3 mio. | 1 | |
| 2018 | 0 | 0 | 100 | 100 | - |
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 1.054 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Kariya Pharmaceuticals ApS has published its annual report for 2025. Gross profit came to DKK -32,093,186, and the net result was DKK -26,490,250.
Contact info changed: new website: www.kariyapharma.com (June 30, 2026).
As of June 25, 2026, JUMIKA Holdings ApS is registered as an owner of Kariya Pharmaceuticals ApS with an ownership share of 25%.
As of June 25, 2026, is registered as an owner of Kariya Pharmaceuticals ApS with an ownership share of 20%.
As of June 25, 2026, is registered as an owner of Kariya Pharmaceuticals ApS with an ownership share of 25%.
Contact info changed: new website: www.kariyapharma.com (June 19, 2026).
Kariya Pharmaceuticals ApS has published its annual report for 2024. Gross profit came to DKK -3,624,681, and the net result was DKK -2,599,412.
Kariya Pharmaceuticals ApS has published its annual report for 2023. Gross profit came to DKK -10,223,064, and the net result was DKK -8,022,549.
Kariya Pharmaceuticals ApS has published its annual report for 2022. Gross profit came to DKK -13,798,220, and the net result was DKK -14,005,570.
As of May 3, 2023, John Connell has joined the board of directors of Kariya Pharmaceuticals ApS.
As of April 27, 2023, Claus Elsborg Olesen has joined the board of directors of Kariya Pharmaceuticals ApS.
As of April 27, 2023, Ian Rodney Laquian has joined the board of directors of Kariya Pharmaceuticals ApS.
As of April 27, 2023, Mikael Søndergaard Thomsen has joined the board of directors of Kariya Pharmaceuticals ApS.
As of April 27, 2023, Christian Hölscher has joined the board of directors of Kariya Pharmaceuticals ApS.
Kariya Pharmaceuticals ApS has published its annual report for 2021. Gross profit came to DKK -2,712,238, and the net result was DKK -3,255,075.
As of September 16, 2021, Thomsen Pharma ApS is registered as an owner of Kariya Pharmaceuticals ApS with an ownership share of 5%.
On August 23, 2021, the company changed its name from Kariya Pharmaceuticals IVS to Kariya Pharmaceuticals ApS.
Kariya Pharmaceuticals ApS has published its annual report for 2020. Gross profit came to DKK -1,493,450, and the net result was DKK -2,207,146.
As of November 12, 2020, Christian Hölscher is registered as director of Kariya Pharmaceuticals ApS.
As of November 12, 2020, Ian Rodney Laquian has stepped down as director of Kariya Pharmaceuticals ApS.
Kariya Pharmaceuticals ApS has published its annual report for 2019. Gross profit came to DKK -6,324,847, and the net result was DKK -7,304,278.
Kariya Pharmaceuticals ApS has published its annual report for 2018. Gross profit came to DKK 0, and the net result was DKK 0.
As of January 11, 2019, Ian Rodney Laquian is registered as director of Kariya Pharmaceuticals ApS.
As of November 28, 2018, Ian Rodney Laquian has stepped down as adm. dir. of Kariya Pharmaceuticals ApS.
As of January 18, 2018, Ian Rodney Laquian is registered as adm. dir. of Kariya Pharmaceuticals ApS.
Kariya Pharmaceuticals ApS was founded on January 18, 2018.
Companies in the same industry and area
CVR 45436497
CVR 46543912
CVR 40766383
CVR 42731323
CVR 38599119
companydata.dk